A Second p53 Binding Site in the Central Domain of Mdm2 Is Essential for p53 Ubiquitination
Jianhong Ma(GlaxoSmithKline (United Kingdom)), Zhihong Lai(South College), Kyung Johanson(South College), Thau Ho(GlaxoSmithKline (United States)), Robert B. Kirkpatrick(Protein Express (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Hong Zhang(Huaibei Normal University), Kurt R. Auger(Research Triangle Park Foundation), John D. Martin(Harvard University), and Robert A. Copeland(South College), Michael Grooms(Protein Express (United States))
Cited by 67
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
|Biochemistry|2008|550